FDA OK’s Emergent BioSolutions plant to resume manufacturing J&J’s Covid-19 vaccine
By Jen Christensen and Nadia Kounang, CNN Emergent BioSolutions announced Thursday that the US Food and Drug Administration will allow it to resume…
Continue Reading